Immune checkpoint inhibitors in the treatment of cancer
CONCLUSION: This review also highlighted the most common adverse effects caused by ICIs and which affect people in different ways.PMID:33823768 | DOI:10.2174/1574884716666210325095022
Source: Current Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Wissam Zam Lina Ali Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Drugs & Pharmacology | Head and Neck Cancer | Hepatocellular Carcinoma | HNSCC | Immunotherapy | Liver Cancer | Lymphoma | Melanoma | Non-Small Cell Lung Cancer | Skin Cancer | Squamous Cell Carcinoma | Yervoy